Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 CNS 1

Conditions

Brain Neoplasms 1

Interventions

Temozolomide 79 Magnetic Resonance Spectroscopy 68 Specimen Handling 45 Radiotherapy 42 Bevacizumab 29 Radiosurgery 27 Cyclophosphamide 27 Radiation 20 pembrolizumab 19 Blood Specimen Collection 19 fludarabine 16 Nivolumab 16 Irinotecan 15 Carboplatin 13 Biopsy 13 Etoposide 12 Vincristine 11 Pemetrexed 11 Lomustine 11 dinutuximab 9 Surgical Procedures, Operative 9 trametinib 8 abemaciclib 8 Ipilimumab 8 naxitamab 7 fluciclovine F-18 7 Watchful Waiting 7 Topotecan 7 Proton Therapy 7 Magnetic Resonance Imaging 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Oxygen × CNS × Clear all

NCT03649880 2025-03-25

Feasibility of FMISO in Brain Tumors

OHSU Knight Cancer Institute

Phase 2 Recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡